Confidential mandate

Field-Service Transformation Command Leader

Urgent / Unplanned

Field-Service Transformation Command Leader mandate in Chicago, United States · Diagnostic Imaging Equipment

A diagnostic-equipment manufacturer needs executive command after a failed dispatch rollout extended hospital downtime, exhausted engineers and triggered penalty claims across its largest service region.

The mandate

A dispatch-and-mobile-work rollout collapsed the distinction between emergency clinical downtime, planned maintenance and low-priority administrative calls. Engineer routes became unstable, parts arrived after visits and remote specialists were engaged too late, causing hospitals to escalate through commercial executives. The service president departed after quality review found incomplete maintenance evidence and fatigue-related scheduling breaches. The interim assumes executive control of North American service while regulated corrections, customer remediation and transformation recovery occur together.

The seat must be filled within four weeks for a twelve-month window. Days one through twenty establish clinical-criticality triage, safe rostering, parts visibility and a single incident route for the top fifty hospital systems. By month three, regional backlogs and disputed work-order statuses must be reconciled. The middle six months redesign planning and field leadership; the final quarter proves the model through winter disruption and transfers ownership to a permanent service executive being recruited separately.

Handover requires validated maintenance records, sustainable response performance by equipment criticality, closed fatigue exceptions, a stable engineering roster and ninety days without manual dispatch intervention from the executive office. The successor will receive customer-specific recovery commitments, parts-risk segmentation, remote-resolution pathways, competence constraints, quality CAPA dependencies and a tested weekly service review. Finance must reconcile warranty, contract, penalty and expediting effects without turning clinical uptime into a purely financial score.

The interim may reassign field capacity, pause low-priority campaigns, revise dispatch and escalation rules, approve temporary service partners within quality status, change regional leadership duties and settle customer service credits up to USD500,000. Permanent senior appointments, workforce reductions, product safety determinations, reportability judgments, union agreement changes and settlements above that threshold require designated executive, quality, legal or board approval. The interim can reject a technology release that fails operational acceptance but cannot alter validated product software.

New-product installation growth, global service reorganisation, equipment design changes and replacement of the core customer platform sit outside this assignment. The leader is not being asked to make regulatory submissions, certify product safety or renegotiate the entire service-contract portfolio. The remit is a controlled North American recovery that restores hospital confidence, truthful maintenance evidence and an operable field system while preserving formal quality independence and avoiding unsustainable heroic overtime.

Why this seat is open

The failed rollout converted a transformation programme into a customer and quality crisis, and the former executive left during the corrective-action review. Regional leaders can solve individual escalations but lack authority to rebalance capacity and unwind flawed central rules. The board needs a time-bounded service operator who understands clinical consequence as well as route, parts and contract economics.

What you will own

  • Reclassify the entire service backlog by clinical criticality, safety dependency, contractual exposure and evidence completeness.
  • Decide capacity allocation among emergency response, preventive maintenance, installations and lower-value campaigns using explicit rules.
  • Restore safe engineer rosters, competence matching, remote escalation and travel limits across every service region.
  • Rebuild parts positioning and forward-stocking decisions from failure pattern, lead time and installed-base consequence.
  • Chair hospital recovery reviews that link commitments, work orders, quality actions, credits and accountable closure evidence.
  • Set operational acceptance tests for dispatch releases and stop deployments that recreate unsafe or opaque work queues.
  • Induct the permanent successor through live winter scenarios, customer meetings and a documented authority handover.

Candidate qualifications

  • Has led regulated field-service recovery for diagnostic, medical-device or similarly safety-critical installed equipment.
  • Can evidence restoration of uptime and maintenance compliance after a dispatch, mobile-work or scheduling failure.
  • Understands clinical criticality, field competence, spare-parts networks, remote resolution, contracts and quality-system boundaries.
  • Has exercised executive authority across large dispersed workforces while protecting fatigue rules and truthful completion records.
  • Can work with hospital executives, quality officers, engineers, unions, technology teams and service commercial leaders.
  • Has handed a stabilised transformation to a permanent successor without leaving dependence on a central war room.

Non-negotiables

  • Can start within four weeks and travel fortnightly to service hubs or affected hospital systems.
  • Will not recategorise overdue maintenance or suppress safety-relevant evidence to improve reported performance.
  • Brings direct installed-base service leadership; manufacturing operations experience alone does not meet the requirement.
  • Can distinguish operational acceptance from formal product-safety and regulatory decisions owned by independent specialists.
  1. 49 words maximum. What is the earliest date you can assume the Chicago seat and begin regional travel?
  2. 49 words maximum. Which field-service backlog classification changed your capacity plan most materially during a regulated recovery?
  3. 49 words maximum. Describe a dispatch release you stopped and the frontline evidence that justified the decision.

This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.